ResMed | RMD - Sales Revenues

ResMed reported $1.2B in Sales Revenues for its fiscal quarter ending in March of 2024.

Sales Change Date
Ansell USD 784.9M 34.9M Dec/2023
AtriCure USD 106.54M 8.25M Dec/2023
Baxter International USD 3.88B 177M Dec/2023
Cochlear AUD 1.1B 47.6M Dec/2023
Cooper Companies USD 931.6M 4.5M Dec/2023
CSL USD 8.05B 1.93B Dec/2023
Dexcom USD 921M 113.5M Mar/2024
Edwards Lifesciences USD 1.6B 65.9M Mar/2024
Fisher Paykel Healthcare NZD 803.7M 86.8M Jun/2023
Globus Medical USD 616.53M 232.9M Dec/2023
Haemonetics USD 336.25M 18.07M Dec/2023
Hologic USD 1.01B 67.8M Dec/2023
Idexx Laboratories USD 901.6M 13.93M Dec/2023
Insulet USD 509.8M 77.1M Dec/2023
Integra LifeSciences USD 397.04M 14.62M Dec/2023
Intuitive Surgical USD 1.89B 38.3M Mar/2024
Masimo USD 548.9M 70M Dec/2023
Medtronic USD 8.09B 105M Dec/2023
Philips EUR 5.06B 591M Dec/2023
Ramsay Health Care AUD 8.09B 962.2M Dec/2023
ResMed USD 1.2B 37.2M Mar/2024
Sigma Healthcare AUD 1.68B 53.31M Dec/2023
Sonic Healthcare AUD 4.31B 218.93M Dec/2023
Steris USD 1.4B 53.28M Dec/2023
Teleflex USD 773.91M 27.52M Dec/2023
Thermo Fisher Scientific USD 10.34B 546M Mar/2024